Chronic Overexpression of Neuronal NRG1-III in Mice Causes Long-Term Detrimental Changes in Lower Motor Neurons, Neuromuscular Synapses and Motor Behaviour
Authors:
- Sara SalvanySSSara Salvany
- Sara HernándezSHSara Hernández
- Anna CasanovasACAnna Casanovas
- Sílvia GrasSGSílvia Gras
- Lídia PiedrafitaLPLídia Piedrafita
- Mar Bosch-QueraltMBMar Bosch-Queralt
- Markus H. SchwabMSMarkus H. Schwab
- Jordi CalderóJCJordi Calderó
- Josep E. EsquerdaJEJosep E. Esquerda
- Olga TarabalOTOlga Tarabal
Open Access
- 26 November 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11421
Abstract
Neuregulins (NRGs) are ligands of tyrosine kinase receptors from the ErbB family and play multiple developmental roles. NRG1–ErbB signaling regulates myelination and has been associated with amyotrophic lateral sclerosis (ALS) pathology. Given the potential therapeutic relevance of this pathway for motor neuron (MN) diseases, we employed a transgenic (TG) mouse with persistent neuronal overexpression of neuregulin type III (NRG1-III) to investigate its impact on the neuromuscular system. We performed an analysis of phenotypic changes in this TG model, including motor behavior, neuropathological evaluation by immunocytochemistry and ultrastructural examination of the spinal cord, peripheral nerves, and neuromuscular junctions (NMJs). Calcium dynamics in cultured MNs were also examined. We found that cholinergic C-boutons on TG MNs, where NRG1-III typically accumulates, exhibited upregulation of C-bouton-associated proteins and expansion of the subsynaptic cistern (SSC)-associated endoplasmic reticulum. Calcium imaging revealed altered homeostasis in TG MNs, accompanied by the upregulation of molecules linked to axonal plasticity. At NMJs, regressive changes involving autophagic dysregulation were observed. These alterations were accompanied by increased motor activity in behavioral tests. Overall, our findings indicate that persistently elevated NRG1-III signaling compromises MN connectivity and long-term health, a factor to consider when developing therapeutic strategies for neurodegenerative diseases such as ALS.Keywords
All Related Versions
Funding Information
- Ministerio de Ciencia e Innovación (PID2021-122785OB-I00)
- Marató de TV3 Foundation (202005-30)
This publication has 77 references indexed in Scilit:
- Neuromuscular Junction Dysfunction in Amyotrophic Lateral SclerosisMolecular Neurobiology, 2022
- Motoneuron deafferentation and gliosis occur in association with neuromuscular regressive changes during ageing in miceJournal of Cachexia, Sarcopenia and Muscle, 2020
- Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral SclerosisNeurotherapeutics, 2020
- NMDA Receptors Regulate Neuregulin 2 Binding to ER-PM Junctions and Ectodomain ReleaseMolecular Neurobiology, 2019
- Bace1 processing of NRG1 type III produces a myelin‐inducing signal but is not essential for the stimulation of myelinationGlia, 2011
- Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampusActa Neuropathologica, 2011
- Large cholinergic nerve terminals on subsets of motoneurons and their relation to muscarinic receptor type 2Journal of Comparative Neurology, 2003
- MMP-2 and MMP-9 Increase the Neurite-Promoting Potential of Schwann Cell Basal Laminae and Are Upregulated in Degenerated NerveMolecular and Cellular Neuroscience, 2000
- Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses.The EMBO Journal, 1995
- Displacement of synaptic terminals from regenerating motoneurons by microglial cellsCell and tissue research, 1968